What Humacyte Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 5 |
| Sells | 0 | 2 |
| Total trades | 3 | 9 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 50,000 | 740,018 |
| Disposed | 0 | 91,774 |
| Net activity | +50,000 | +648,244 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Jones Keith Anthony | Director | Sep 14 | Open-market buy · P | +10,000 | $0.56 | +$5.62K | 50,000 |
| Jones Keith Anthony | Director | Aug 20 | Open-market buy · P | +10,000 | $0.69 | +$6.93K | 40,000 |
| Jones Keith Anthony | Director | Aug 17 | Open-market buy · P | +30,000 | $0.59 | +$17.8K | 30,000 |
| Sebelius Kathleen | Director | May 19 | Open-market buy · P | +56,818 | $0.88 | +$50K | 148,025 |
| Parikh Shamik J | Chief Medical Officer | May 18 | Sale for tax withholding · S | −45,887 | $0.90 | −$41.1K | 272,713 |
| Sander Dale A. | CFO and Chief Corp. Dev. Off | May 18 | Sale for tax withholding · S | −45,887 | $0.90 | −$41.1K | 267,213 |
| Constantino Michael T. | Director | May 18 | Open-market buy · P | +11,000 | $0.89 | +$9.84K | 43,950 |
| Parikh Shamik J | Chief Medical Officer | Nov 16 | Grant / award · A | +311,100 | — | — | 318,600 |
| Sander Dale A. | CFO and Chief Corp. Deve. Off. | Nov 16 | Grant / award · A | +311,100 | — | — | 313,100 |
| Dougan Brady W | Director | Aug 20 | Open-market sale · S | −591,685 | $1.58 | −$935K | 0 |
| Niklason Laura E | President, CEO and Director | Aug 20 | Open-market sale · S | −591,685 | $1.58 | −$935K | 0 |
| Dougan Brady W | Director | Aug 19 | Open-market sale · S | −1,100,000 | $1.63 | −$1.79M | 591,685 |
| Niklason Laura E | President, CEO and Director | Aug 19 | Open-market sale · S | −1,100,000 | $1.63 | −$1.79M | 591,685 |
| Dougan Brady W | Director | Aug 18 | Open-market sale · S | −549,360 | $1.83 | −$1.01M | 1,691,685 |
| Niklason Laura E | President, CEO and Director | Aug 18 | Open-market sale · S | −549,360 | $1.83 | −$1.01M | 1,691,685 |
| Scheessele William John | Chief Commercial Officer | Apr 14 | Open-market buy · P | +6,493 | $1.54 | +$10K | 22,018 |
| Parikh Shamik J | Chief Medical Officer | Apr 10 | Open-market buy · P | +7,500 | $1.55 | +$11.6K | 7,500 |
| Sander Dale A. | CFO and Chief Corp. Deve. Off. | Apr 10 | Open-market buy · P | +20,000 | $1.53 | +$30.6K | 40,600 |
| Sebelius Kathleen | Director | Apr 08 | Open-market buy · P | +50,000 | $1.32 | +$66K | 91,207 |
| Green Charles Bruce | Director | Apr 08 | Open-market buy · P | +6,000 | $1.29 | +$7.74K | 8,400 |
Loading...
